RPS set to cut two senior leadership jobs
Working towards its five-year strategy, the Royal Pharmaceutical Society (RPS) has put some plan in place to change its existing structure at the executive...
Government allocates £260m to boost healthcare research and manufacturing
The government on Wednesday (March 2) announced an investment of £260 million to support research, development and manufacturing of new drugs, devices and diagnostics.
Of...
Pharmaceutical company Syri fined for manufacturing defective medicine
London-based pharmaceutical manufacturer, Syri Ltd, has been fined £51,000 and ordered to pay costs of £104,898 by Aylesbury Crown Court, after being convicted of supplying...
Free flu jabs: 50-64-year-olds fall out of purview in 2022-23
The NHS flu vaccination service in 2022-23 will be offered to patient groups eligible in line with pre-pandemic recommendations, the NHS England and NHS...
Former Avicenna executive director Bharti Patel joins Alitam executive board
Alitam Group, the 100-plus pharmacy store consolidation, has appointed Bharti Patel, the former group executive director of Avicenna to its executive board.
Patel, who was...
NICE recommends tucatinib for advanced breast cancer
NICE has recommended use of tucatinib as an option to treat HER2-positive breast cancer that has spread in people who have already tried 2...
Novo Nordisk launches two smart connected insulin pens in the UK
Global healthcare company, Novo Nordisk has announced availability of two smart connected insulin pens, NovoPen® 6 and NovoPen Echo® Plus on prescription for diabetic people...
RPS to host sessions to help shape response for NHS primary care review
The Royal Pharmaceutical Society (RPS) will be hosting two sessions for members to help them shape response to an NHS review of primary care...
England scraps mandatory Covid shots for health staff
Health and social care workers in England, including those working in community pharmacy, will no longer have to have a Covid shot or jab...
Novavax expects to apply for full approval of Covid vaccine later this year
American biotechnology company Novavax said on Monday (February 28) it would pursue full approval of its Covid-19 vaccine in the second half of this...
Current Issue March 2024
